Culper Research says it is shot Adma Biologics (ADMA)
Context
Culper Research's short position on Adma Biologics suggests they anticipate further declines in the stock, likely due to perceived weaknesses in the company's fundamentals or market position. This could set off a ripple effect in the sector as investors reevaluate their positions in similar firms, potentially impacting broader market sentiment toward biotech shares.
Trade the TapeGet this analysis live, the moment it breaksNewsquawk's real-time dashboard delivers market-moving headlines and instant context to your desk before the rest of the market reacts.
Open Dashboard#EU SESSION#US SESSION#US EQUITIES